Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals-Reference-Cited by-同舟云学术

Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals

Published:2022-04-01 Issue:4 Volume:13 Page:9184-9196
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Wang Ying¹,Cai Fei¹,Li Gang¹,Tao Yong²

Affiliation:

1. Department of Cardiology, Nantong Third People’s Hospital and the Third People’s Hospital Affiliated to Nantong University, Nantong, People’s Republic of China

2. Department of Intensive Care Unit, Tumor Hospital Affiliated to Nantong University, Nantong Tumor Hospital, Nantong, People’s Republic of China

Funder

reported that there is no funding associated with the work featured in this article

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2051859

Reference34 articles.

1. β-Cell function in type 2 diabetes

2. Prevalence and Control of Diabetes in Chinese Adults

3. Molecular mechanisms of diabetic cardiomyopathy

4. Li K, Zhai M, Jiang L, et al. Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 pathway, Oxid. Med. Cell. Longev. 2019 (2019) 6746907.

5. Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12

2. Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets;Chinese Medical Journal;2024-03-25

3. Association between lactate dehydrogenase and the risk of diabetic kidney disease in patients with type 2 diabetes;Frontiers in Endocrinology;2024-03-19

4. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism;Fitoterapia;2023-07

5. Liraglutide alleviates myocardial ischemia‒reperfusion injury in diabetic mice;Molecular and Cellular Endocrinology;2023-07